4basebio (XTER:88Q) Interest Expense : €-0.20 Mil (TTM As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is 4basebio Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. 4basebio's interest expense for the six months ended in Jun. 2023 was € -0.11 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2023 was €-0.20 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. 4basebio's Operating Income for the six months ended in Jun. 2023 was € -4.39 Mil. 4basebio's Interest Expense for the six months ended in Jun. 2023 was € -0.11 Mil. 4basebio did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

4basebio Interest Expense Historical Data

The historical data trend for 4basebio's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4basebio Interest Expense Chart

4basebio Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Interest Expense

-0.13

-0.10

-0.13

-0.10

4basebio Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Interest Expense	Get a 7-Day Free Trial			-0.04	-0.10	-0.02	-0.08	-0.11

4basebio Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.20 Mil.

4basebio (XTER:88Q) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

4basebio's Interest Expense for the six months ended in Jun. 2023 was €-0.11 Mil. Its Operating Income for the six months ended in Jun. 2023 was €-4.39 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2023 was €0.00 Mil.

4basebio's Interest Coverage for the quarter that ended in Jun. 2023 is calculated as

4basebio did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

4basebio (XTER:88Q) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4basebio PLC (XTER:88Q) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

4BB:UK

Address

25 Norman Way, Over, Cambridge, GBR, CB24 5QE

Website

https://www.4basebio.com

4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for the effective and safe delivery of these DNA-based products to patients. Its country of operation is the UK. It is engaged in the manufacturing and supply of high-purity, synthetic DNA for research, therapeutic and pharmacological use.

4basebio (XTER:88Q) Headlines

No Headlines